81 related articles for article (PubMed ID: 22504386)
1. Complete pathological response after chemotherapy alone in a patient with pancreatic adenocarcinoma.
Carbonell S; Espinosa J; Zarco A; de-Madaria E; de la Hoz J; Yuste A; Payá A; Lluís F
Pancreas; 2012 May; 41(4):657-9. PubMed ID: 22504386
[No Abstract] [Full Text] [Related]
2. Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature.
Valeri S; Borzomati D; Nappo G; Perrone G; Santini D; Coppola R
Pancreatology; 2014; 14(5):425-30. PubMed ID: 25278312
[TBL] [Abstract][Full Text] [Related]
3. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
4. [Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].
Shi YX; Xu RH; Jiang WQ; Zhang L; Lin TY; Li YH; Xia ZJ; Luo HY; Han B; Wang F; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1381-4. PubMed ID: 18076807
[TBL] [Abstract][Full Text] [Related]
5. [Pancreatic cancer--diagnostics and therapy].
Schramm H
Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
[No Abstract] [Full Text] [Related]
6. Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer.
Tudini M; Palluzzi E; Cannita K; Mancini M; Santomaggio A; Bruera G; Baldi PL; Pelliccione M; Ricevuto E; Ficorella C
Oncol Rep; 2012 Feb; 27(2):423-32. PubMed ID: 22020810
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
Quek R; Lim WT; Foo KF; Koo WH; A-Manaf A; Toh HC
Acta Oncol; 2007; 46(7):1032-4. PubMed ID: 17917832
[No Abstract] [Full Text] [Related]
8. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from a complete remission of advanced metastatic pancreatic ductal adenocarcinoma.
Mathew BM; Daas AY; Centeno BA; Hoffe S; Valone T; Patel M; Springett GM
Clin Adv Hematol Oncol; 2012 May; 10(5):340-3. PubMed ID: 22706548
[No Abstract] [Full Text] [Related]
10. Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure.
Chauhan VP; Boucher Y; Ferrone CR; Roberge S; Martin JD; Stylianopoulos T; Bardeesy N; DePinho RA; Padera TP; Munn LL; Jain RK
Cancer Cell; 2014 Jul; 26(1):14-5. PubMed ID: 25026209
[No Abstract] [Full Text] [Related]
11. [nab-Paclitaxel as new therapeutic option for pancreatic cancer].
Michl P
Z Gastroenterol; 2013 Nov; 51(11):1329-30. PubMed ID: 24243574
[No Abstract] [Full Text] [Related]
12. Response to Chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning.
DelGiorno KE; Carlson MA; Osgood R; Provenzano PP; Brockenbough JS; Thompson CB; Shepard HM; Frost GI; Potter JD; Hingorani SR
Cancer Cell; 2014 Jul; 26(1):16-7. PubMed ID: 25026210
[No Abstract] [Full Text] [Related]
13. Combination of Anti-miRNAs Oligonucleotides with Low Amounts of Chemotherapeutic Agents for Pancreatic Cancer Therapy.
Passadouro M; Faneca H
Methods Mol Biol; 2018; 1699():135-154. PubMed ID: 29086375
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic ductal adenocarcinoma: metastatic disease.
Muñoz Martín AJ; Adeva J; Martínez-Galán J; Reina JJ; Hidalgo M
Clin Transl Oncol; 2017 Dec; 19(12):1423-1429. PubMed ID: 28623515
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation: a novel pancreatic cancer therapy.
Weiss MJ; Wolfgang CL
Curr Probl Cancer; 2013; 37(5):262-5. PubMed ID: 24331180
[No Abstract] [Full Text] [Related]
16. A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling.
Cowan RW; Maitra A; Rhim AD
Gastroenterology; 2015 Dec; 149(7):1685-8. PubMed ID: 26526714
[No Abstract] [Full Text] [Related]
17. Chemotherapy: NAPOLI-1: winning scoop for metastatic pancreatic cancer.
Hutchinson L
Nat Rev Clin Oncol; 2016 Jan; 13(1):2-3. PubMed ID: 26667974
[No Abstract] [Full Text] [Related]
18. Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions.
De Souza AL; Saif MW
JOP; 2014 Mar; 15(2):144-6. PubMed ID: 24618440
[TBL] [Abstract][Full Text] [Related]
19. Nanoliposomal irinotecan in metastatic pancreatic cancer.
Milosevic I; Drysdale H; Goldacre B;
Lancet; 2016 May; 387(10032):1997. PubMed ID: 27203772
[No Abstract] [Full Text] [Related]
20. Therapeutics: Disrupting a survival signal.
McCarthy N
Nat Rev Cancer; 2013 Sep; 13(9):608-9. PubMed ID: 23903094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
